glp 1 ra heart failure Frontiers Glucagon-like peptide 1 receptor agonists:

Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial

The combination of the medication and preexisting gastroparesis symptoms could exacerbate nausea and vomiting. I dont recommend people who have a history of an eating disorder take GLP-1 drugs unless they absolutely need treatment, says Sue Decotiis, MD, triple board-certified physician in New York City

Short-acting GLP1s cause more nausea

Drug Resistance When weight-loss medications fail to deliver results, users may opt for stronger, more potent drugs, leading to drug resistance

J Diabetes Sci Technol Advance Access published on Mar 11, 2024, doi: 10.1177/19322968241231565

There is now a rather bewildering array of DTC prices for patients seeking access to GLP-1s for weight loss